Replies to post #287030 on Anavex Life Sciences Corp (AVXL)

[raja48185]

Seems Anavex could kick financial butt simply by rolling out blarcamesine as a sleeping aid.

The added benefit would be improved mitochondrial function. And a paucity of side effects.

Data needs to tell the story. Till then market does not do favors to any biotech stock, especially baby(small cap) bio techs.

[Steady_T]

You do realize that for Anavex to get 2-73 approved for a sleeping aid it would have to start an entirely new set of trials.

Sleep is already a secondary end point is several trials so in effect that process is already underway.